J9041 Injection, bortezomib, 0.1mg
J-Codes
Also known as: bortezomib, Velcade
Intravenous injection of bortezomib, a proteasome inhibitor chemotherapy agent, dosed per 0.1 milligram.
Clinical Context
First-line therapy for multiple myeloma and mantle cell lymphoma. Inhibits proteasome function, inducing cell cycle arrest and apoptosis.
RVU Breakdown
| Work RVU | 0.00 |
| Practice Expense RVU | 0.00 |
| Malpractice RVU | 0.00 |
| Total RVU | 0.00 |
Specialties
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.